Sonoma Pharmaceuticals Inc (SNOA) — Financial Flexibility Index
Sonoma Pharmaceuticals Inc (SNOA) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-717.00K (operating CF $-764.00K minus capex $47.00K) represents 0% of total liabilities ($10.19 Million). Check asset allocation strategy of Sonoma Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sonoma Pharmaceuticals Inc Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Sonoma Pharmaceuticals Inc across 21 annual periods. See Sonoma Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sonoma Pharmaceuticals Inc (2005–2025)
Year-by-year free cash flow to debt coverage for Sonoma Pharmaceuticals Inc. For the full company profile including market capitalisation, see SNOA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $-8.00K | $-88.00K | $9.28 Million | ▲ +99.7% |
| 2024 | -0.28x | $-2.38 Million | $-2.40 Million | $8.60 Million | ▲ +61.2% |
| 2023 | -0.71x | $-5.88 Million | $-6.15 Million | $8.25 Million | ▼ -75.9% |
| 2022 | -0.41x | $-4.11 Million | $-4.25 Million | $10.15 Million | ▼ -21.9% |
| 2021 | -0.33x | $-3.20 Million | $-3.38 Million | $9.62 Million | ▲ +32.3% |
| 2020 | -0.49x | $-4.38 Million | $-4.59 Million | $8.94 Million | ▲ +83.3% |
| 2019 | -2.93x | $-11.62 Million | $-11.72 Million | $3.96 Million | ▲ +7.1% |
| 2018 | -3.16x | $-12.25 Million | $-12.44 Million | $3.88 Million | ▼ -63.6% |
| 2017 | -1.93x | $-7.77 Million | $-8.17 Million | $4.03 Million | ▲ +15.9% |
| 2016 | -2.29x | $-8.40 Million | $-8.75 Million | $3.66 Million | ▼ -4.8% |
| 2015 | -2.19x | $-6.55 Million | $-6.69 Million | $2.99 Million | ▼ -335.7% |
| 2014 | -0.50x | $-4.39 Million | $-4.89 Million | $8.73 Million | ▼ -403.0% |
| 2013 | 0.17x | $1.41 Million | $1.15 Million | $8.48 Million | ▲ +139.1% |
| 2012 | -0.42x | $-3.70 Million | $-4.03 Million | $8.71 Million | ▲ +30.5% |
| 2011 | -0.61x | $-4.25 Million | $-4.43 Million | $6.96 Million | ▲ +70.2% |
| 2010 | -2.05x | $-6.50 Million | $-6.64 Million | $3.17 Million | ▲ +60.4% |
| 2009 | -5.17x | $-16.44 Million | $-16.83 Million | $3.18 Million | ▼ -151.6% |
| 2008 | -2.06x | $-16.83 Million | $-17.45 Million | $8.18 Million | ▼ -44.0% |
| 2007 | -1.43x | $-17.21 Million | $-18.08 Million | $12.05 Million | ▲ +61.9% |
| 2006 | -3.75x | $-20.05 Million | $-20.52 Million | $5.35 Million | ▼ -42.1% |
| 2005 | -2.64x | $-12.49 Million | $-13.53 Million | $4.74 Million | — |